Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-04-20
2010-11-23
Nguyen, Bao-Thuy L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S345000, C435S336000, C436S547000, C436S548000
Reexamination Certificate
active
07838245
ABSTRACT:
The present invention relates to the use of protachykinin and/or fragments thereof that can be isolated from body fluids, tissues or other bioiological samples and therefore, serves as a marker peptide for medical diagnosis of diseases/disorders of the central nervous system, including Alzheimer's disease, Parkinson's disease, depression and/or conditions of pain, neurological, endocrinological, cerebral, muscular, local, systemic, chronic, inflammatory diseases, infectious diseases comprising bacterial and viral infections, meningitis, sepsis, Crohn's disease, colitis ulcerosa, sickle cell anemia, ischemia, amyotrophic lateral sclerosis, arthritis comprising rheumatoid arthritis, bronchitis, hyperalgesia, asthma, intoxication comprising bacterial intoxication, immunological disorders, poly/-trauma comprising cranio-cerebral trauma, tumors/cancer, stroke, stress, atopis dermatitis, HIV, Huntington's disease, burns, schizophrenia, Hirschsprung's disease, allergies, familial dysautononmia (Riley Day syndrome), hematopoietic disorders, gliomas comprising glioblastomas and astrocytomas, disorders of the blood brain barrier. The invention further provides antibodies for binding to certain proteins and their fragments, more specifically protachykinin and protachykinin peptides. In accordance with the invention, a kit useful for the above-mentioned diagnosis is also provided.
REFERENCES:
patent: 5268359 (1993-12-01), Harmar et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 2006/0053498 (2006-03-01), Bejanin et al.
patent: 1241257 (2002-09-01), None
patent: 87/07643 (1987-12-01), None
patent: WO 98/22497 (1998-05-01), None
patent: 02/103016 (2002-12-01), None
patent: 2004/076614 (2004-09-01), None
The Sanger Centre. Genome Research. 1998. vol. 8:1097-1108.
Theodorsson-Norheim et al., Eur. J. Biochem. 166. pp. 6930698. 1987.
Harmar et al., FEBS 4102. vol. 208, No. 1. Nov. 1986, pp. 67-72.
International Search Report for corresponding European Patent Application EP2005/004254, 2006.
Dandona et al., “Procalcitonin Increase after Endotoxin Injection in Normal Subjects”, Journal of Clinical Endocrinology and Metabolism, 1994, vol. 79(5), 1605-1608.
Bergmann Andreas
Ernst Andrea
Heslin Rothenberg Farley & & Mesiti P.C.
Nguyen Bao-Thuy L
Sphingotec GmbH
LandOfFree
Use of precursors of tachykinins and/or their fragments in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of precursors of tachykinins and/or their fragments in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of precursors of tachykinins and/or their fragments in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4175599